MedTrace Logo

Use of Morphine Gel Topically in Patients With Stage 2-3 Wounds

NCT00755989 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-07-20

No results posted yet for this study

Summary

Morphine gel applied topically to wounds will reduce wound pain and decrease patients use of oral and intravenous pain medications, therefore reducing side effects.

Conditions

  • Wounds

Interventions

OTHER

None available

Sponsors & Collaborators

  • Banner Health

    lead OTHER

Principal Investigators

  • Mary Whitmer, MSN,FNP, APRN BC-PCM · Banner Health

Study Design

Allocation
NA
Purpose
OTHER
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00755989 on ClinicalTrials.gov